Faculty profile

Harriet Feilotter

Back to faculty

ProfessorPathologyQueen's University

Harriet Feilotter

Professor

Pathology

Queen's University

Kingston, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
15 publications in the last five years, latest in 2025.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CFI), most recently in 2007.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,734

Citations

115

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Queen's University profile.

Latest papers

Multiplex PCR for the Rapid Diagnosis of Myeloproliferative Neoplasms.
Methods in molecular biology (Clifton, N.J.) · 2025
Downregulation of the Unfolded Protein Response Links Metformin Treatment to Good Clinical Outcomes in Colorectal Cancer Patients.
Current oncology (Toronto, Ont.) · 2025
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation
Critical Reviews in Clinical Laboratory Sciences · 2024 · first author

All 35 publications

Latest funding

Seeing the invisible: A precision medicine informatics for cancer biomarkers anchored in time and space
CFI · 2022 · Co-investigator
$75,001
Douglas-Bell Canada Brain Bank, an essential platform for brain research in Canada
BRAIN · 2015 · Co-investigator
$1,883,300
The role of microRNAs in Malignant Melanoma
CIHR · 2009 · Co-investigator
$397,897

All 5 grants and awards

35 publications.

Multiplex PCR for the Rapid Diagnosis of Myeloproliferative Neoplasms.

Semenuk L, Palazzolo A, McCambridge K, Wong H, Rauh MJ, Feilotter H, Quest G

Methods in molecular biology (Clifton, N.J.)20251 citations

DOI: 10.1007/7651_2025_625 PMID: 40227493

Downregulation of the Unfolded Protein Response Links Metformin Treatment to Good Clinical Outcomes in Colorectal Cancer Patients.

Fay ML, Nicol C, Orr C, Wilson B, Hurlbut D, Feilotter H, Davey S

Current oncology (Toronto, Ont.)2025

DOI: 10.3390/curroncol32030138 PMID: 40136342

Guidance for securing approvals for new biomarkers: from discovery to clinical implementation

Harriet E. Feilotter, Christine Bruce, Eleftherios P. Diamandis, Miyo K. Chatanaka, George M. Yousef

Critical Reviews in Clinical Laboratory Sciences202410 citationsFirst author

DOI: 10.1080/10408363.2024.2379278 PMID: 39084247

Variant Classification Discordance: Contributing Factors and Predictive Models.

Ghaedi H, Davey SK, Feilotter H

The Journal of molecular diagnostics : JMD2024Senior author

DOI: 10.1016/j.jmoldx.2023.11.002 PMID: 38008287

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer.

Topham JT, O'Callaghan CJ, Feilotter H, Kennecke HF, Lee YS, Li W, Banks KC, Quinn K, Renouf DJ, Jonker DJ, Tu D, Chen EX, Loree JM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology202370 citationsOpen Access

DOI: 10.1200/jco.22.00364 PMID: 36007218

A Novel Approach to Detect IDH Point Mutations in Gliomas Using Nanopore Sequencing: Test Validation for the Clinical Laboratory.

Mimosa ML, Al-Ameri W, Simpson JT, Nakhla M, Boissinot K, Munoz DG, Das S, Feilotter H, Fattouh R, Saleeb RM

The Journal of molecular diagnostics : JMD202318 citationsOpen Access

DOI: 10.1016/j.jmoldx.2022.12.001 PMID: 36565986

Development of a comprehensive approach to adult hereditary cancer testing in Ontario

Bell KA, Kim R, Aronson M, Gillies B, Awan AA, Chun K, Hart J, Healey R, Kim L, Klaric G

Journal of Medical Genetics20237 citationsSenior author

DOI: 10.1136/jmg-2022-108945

CANTRK A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing

Stockley TL, Lo B, Box A, Corredor AG, DeCoteau J, Desmeules P, Feilotter H, Grafodatskaya D, Greer W, Hawkins C

Journal of Molecular Diagnostics20237 citationsOpen Access

DOI: 10.1016/j.jmoldx.2022.12.004

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies.

Lau SCM, Perdrizet K, Fung AS, Mata DGMM, Weiss J, Holzapfel N, Liu G, Bradbury PA, Shepherd FA, Sacher AG, Feilotter H, Sheffield B, Hwang D, Tsao MS, Cheng S, Cheema P, Leighl NB

JTO clinical and research reports20236 citationsOpen Access

DOI: 10.1016/j.jtocrr.2023.100562 PMID: 37744308

Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.

Husereau D, Bombard Y, Stockley T, Carter M, Davey S, Lemaire D, Nohr E, Park P, Spatz A, Williams C, Pollett A, Lo B, Yip S, El Hallani S, Feilotter H

Current oncology (Toronto, Ont.)20235 citationsSenior authorOpen Access

DOI: 10.3390/curroncol30110700 PMID: 37999120

Seeing the invisible: A precision medicine informatics for cancer biomarkers anchored in time and space

Co-investigatorCFI2022John R. Evans Leaders Fund: John R. Evans Leaders Fund – Funding for research infrastructure

Principal investigators: Ma, Burton

Keywords: image guided surgery, biomarkers, medical imaging, precision medicine computer workstations, video displays, sample preparation platform

$75,001

Douglas-Bell Canada Brain Bank, an essential platform for brain research in Canada

Co-investigatorBRAIN20152014 Platform Grants

Principal investigators: Velde, Christine Vande; Turecki, Gustavo; Rouleau, Guy; Münter, Lisa

Keywords: Mental Health; Other

$1,883,300

The role of microRNAs in Malignant Melanoma

Co-investigatorCIHR2009Operating Grant

Principal investigators: Tron, Victor A

Keywords: Cell Biology; Melanoma; Microrna; Patient Outcome; Systemic Therapy

$397,897

The Terry Fox Foundation Training Program in Transdiciplinary Cancer Research at CIHR

Co-investigatorCIHR2008Terry Fox Foundation Training Grant in Cancer Research at CIHR -Full application

Principal investigators: Mulligan, Lois M

Keywords: Cancer; Cancer Control; Drug Development Fellowships; Graduate Students; Post Doctoral Fellows; Post Md-Fellows; Training Program; Transdisciplinary Research

$1,650,000

A Therapeutic Approach for the Treatment of Melanoma using RNA interference (RNAi)

Principal investigatorCFI2007John R. Evans Leaders Fund: John R. Evans Leaders Fund – Funding for research infrastructure

Principal investigators: Feilotter, Harriet

Keywords: Cancer, melanoma, treatment, RNA interference, apoptosis, ultraviolet radiation, environment,

$96,339

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Harriet Feilotter

Research

Latest papers

Latest funding

Multiplex PCR for the Rapid Diagnosis of Myeloproliferative Neoplasms.

Downregulation of the Unfolded Protein Response Links Metformin Treatment to Good Clinical Outcomes in Colorectal Cancer Patients.

Guidance for securing approvals for new biomarkers: from discovery to clinical implementation

Variant Classification Discordance: Contributing Factors and Predictive Models.

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer.

A Novel Approach to Detect IDH Point Mutations in Gliomas Using Nanopore Sequencing: Test Validation for the Clinical Laboratory.

Development of a comprehensive approach to adult hereditary cancer testing in Ontario

CANTRK A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies.

Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.

Seeing the invisible: A precision medicine informatics for cancer biomarkers anchored in time and space

Douglas-Bell Canada Brain Bank, an essential platform for brain research in Canada

The role of microRNAs in Malignant Melanoma

The Terry Fox Foundation Training Program in Transdiciplinary Cancer Research at CIHR

A Therapeutic Approach for the Treatment of Melanoma using RNA interference (RNAi)

Frequent collaborators

Tracy Stockley

Bekim Sadikovic

Ming Tsao

Dongsheng Tu

Ming-Sound Tsao

Scott Davey

Elizabeth McCready

Andrea Eisen

John Goffin

Daria Grafodatskaya

Kathrin Tyryshkin

Normand Blais

Laura Semenuk

Arnon Adler

Geoffrey Liu

Henry Wong

Michael Rauh

David LeBrun

Jonathan Loree

Ana Andreazza

Aaron Pollett

Lesley Seymour

Joan Knoll

Michael Gollob

Chris Nicol

Christine Orr

Graeme Quest

Brooke Wilson

John Bartlett

Christine Bruce

Andrea Vaags

Kathy Chun

Richard Hegele

Shamini Selvarajah

Christian Marshall

Natasha Leighl

Peter Ainsworth

Jonathan Noujaim

Denis Soulières

Danh Tran-Thanh